Cargando…
Intranasal Administration of Human MSC for Ischemic Brain Injury in the Mouse: In Vitro and In Vivo Neuroregenerative Functions
Intranasal treatment with C57BL/6 MSCs reduces lesion volume and improves motor and cognitive behavior in the neonatal hypoxic-ischemic (HI) mouse model. In this study, we investigated the potential of human MSCs (hMSCs) to treat HI brain injury in the neonatal mouse. Assessing the regenerative capa...
Autores principales: | Donega, Vanessa, Nijboer, Cora H., Braccioli, Luca, Slaper-Cortenbach, Ineke, Kavelaars, Annemieke, van Bel, Frank, Heijnen, Cobi J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232359/ https://www.ncbi.nlm.nih.gov/pubmed/25396420 http://dx.doi.org/10.1371/journal.pone.0112339 |
Ejemplares similares
-
Intranasal Mesenchymal Stem Cell Treatment for Neonatal Brain Damage: Long-Term Cognitive and Sensorimotor Improvement
por: Donega, Vanessa, et al.
Publicado: (2013) -
Assessment of long-term safety and efficacy of intranasal mesenchymal stem cell treatment for neonatal brain injury in the mouse
por: Donega, Vanessa, et al.
Publicado: (2015) -
Pharmacological Neuroprotection after Perinatal Hypoxic-Ischemic Brain Injury
por: Fan, Xiyong, et al.
Publicado: (2010) -
ISBT 128 coding and labeling for cellular therapy products
por: Slaper-Cortenbach, Ineke
Publicado: (2010) -
The rodent endovascular puncture model of subarachnoid hemorrhage: mechanisms of brain damage and therapeutic strategies
por: Kooijman, Elke, et al.
Publicado: (2014)